| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |